|
Stelios Papadopoulos Ph.D. is a co-founder of Anadys and has served as a member of our board of directors since May 2000. Dr. Papadopoulos' career in biotech spans more than two decades. In August 2006 he resigned as Vice Chairman of Cowen & Co. LLC where he had been an investment banker focusing on the biotechnology and pharmaceutical sectors since 2000. Dr. Papadopoulos was an investment banker at PaineWebber Incorporated from 1987 to 2000 most recently serving as Chairman of Paine Webber Development Corp a PaineWebber subsidiary focusing on biotechnology. Prior to joining PaineWebber Incorporated in 1987 he was a Vice President in the Equity Research Department of Drexel Burnham Lambert covering the biotechnology industry and prior to that a biotechnology analyst at Donaldson Lufkin & Jenrette. Before coming to Wall Street Dr. Papadopoulos was on the faculty of the Department of Cell Biology at New York University Medical Center. He continues his affiliation with New York University Medical Center as an Adjunct Associate Professor of Cell Biology. Dr. Papadopoulos holds a Ph.D. in biophysics and an M.B.A. in finance both from New York University. He is co-founder and Chairman of the Board of Exelixis Inc. co-founder and member of the Board of Cellzome Inc. as well as a director of BG Medicine Inc. In the not-for-profit sector he is co-founder and Chairman of Fondation Santé and a member of the Board of Visitors of Duke University Medical Center. | 